Receive our newsletter – data, insights and analysis delivered to you
  1. News
May 8, 2017

University of Strathclyde acquires laser with high peak power

UK's University of Strathclyde has acquired a powerful laser with multiple scientific applications such as medical imaging and cancer treatment.

UK's University of Strathclyde has acquired a powerful laser with multiple scientific applications such as medical imaging and cancer treatment.

Designed and built by technology firm Thales, the laser is reported to recreate the stars' physical conditions such as pressures and temperatures. It also has a high repetition rate for peak powers and the capacity to emit the bursts of light that are equivalent to 20-times the power consumed on Earth in a fraction of a second.

Currently available at the Strathclyde-based Scottish Centre for the Application of Plasma-based Accelerators (SCAPA), the laser has applications in radiotherapy and generating radioisotopes for imaging and cancer therapy.

Strathclyde Physics Department research fellow and SCAPA laser manager Dr Gregor Welsh said: “This is a world-leading laser for any university. Indeed, we believe it is the highest average powered lab-based laser of its type anywhere in the world.

“It acts as a light source which drives the applications and produces X-ray pulses that are short enough to take snapshots of molecular or solid-state processes.”

"Our acquisition of this type of laser reflects Strathclyde’s status as a world-class centre of physics."

The laser is capable of producing beams with peak power of 350TW for 25 femtoseconds. It can produce approximately 14J of energy per pulse at five pulses per second (5Hz).

Content from our partners
“Everything is custom”: Behind the scenes of medical wire solutions
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials

SCAPA director professor Dino Jaroszynski said: “Our acquisition of this type of laser reflects Strathclyde’s status as a world-class centre of physics.

“Its important applications underline Strathclyde’s international reputation for research with impact. It also forms part of a valuable training facility for PhD students.”    

Worth £3.5m, the device has been funded by Strathclyde and the Scottish Universities Physics Alliance (SUPA).

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU